Fused (hetero)cyclic compounds as S1P modulators

US10280159B2 · kind B2 · utility

Assignee

• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Wilhelm Amberg · Ludwigshafen, DE
• Udo Lange · Ludwigshafen, DE
• Hervé Geneste · Schifferstadt, DE
• Michael Ochse · Wiesbaden, DE
• Ralf Biesinger · Ludwigshafen, DE
• Frank Oellien · Ludwigshafen, DE

Key dates

• Filing date: Dec 22, 2016
• Grant date: May 7, 2019
• Expiry date: Dec 22, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/38
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to (hetero)cyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.